Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Biohit Oyj
OYJ
Active
Y-tunnus 0703582-0
Laippatie 1, 00880
Helsinki
Manufacture of other chemical products n.e.c.
·
NACE 2059
Est. 1988 · 38 years old
6 employees
Share
Finland
/
Companies
/
Manufacture of other chemical products n.e.c.
/
Biohit Oyj
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Ledelse
Aktivt ansatte i selskabet
Name
Role
Member since
Current (2)
JH
Jussi Henrik Hahtela
Chief Executive Officer
Chief Executive Officer
2022
JM
Jussi Mikael Sorvo
Person with significant control
Person with significant control
2023
Former (6)
TA
Tiina Annika Puukkoniemi
Audit
Audit
2022 – 2023
SJ
Semi Juhana Korpela
Chief Executive Officer
Chief Executive Officer
2012 – 2021
PA
Pasi Antero Karppinen
Audit
Audit
2014 – 2022
OS
Oili Sinikka Suovaniemi
Confidential Clerk
Confidential Clerk
1992 – 2019
PH
Päivi Helena Siltala
Chief Executive Officer
Chief Executive Officer
2021 – 2022
JP
Jukka Petteri Kainulainen
Confidential Clerk
Confidential Clerk
2021 – 2021
Bestyrelse
Ikke-udøvende tilsyn
Name
Role
Member since
Current (5)
VJ
Vesa-Pekka Juhani Silaskivi
Chairperson
Chairperson
2023
OA
Osmo Antero Suovaniemi
Board of Directors
Board of Directors
2021
LF
Liu Feng
Board of Directors
Board of Directors
2018
KP
Kalle Peter Mika Härkönen
Board of Directors
Board of Directors
2022
LI
Lea Inkeri Paloheimo
Board of Directors
Board of Directors
2023
Former (4)
MH
Matti Heikki Aleksi Härkönen
Board of Directors
Board of Directors
2018 – 2022
FA
Franco Aiolfi
Board of Directors
Board of Directors
2018 – 2023
EH
Eero Heikki Lehti
Board of Directors
Board of Directors
2018 – 2021
TK
Timo Kalevi Joensuu
Board of Directors
Board of Directors
2020 – 2021
Aktionærer
Pr. seneste årsrapport
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on Biohit Oyj
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network